Cargando…
The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652514/ http://dx.doi.org/10.1186/2051-1426-3-S2-P414 |
_version_ | 1782401770788487168 |
---|---|
author | Sansal-Castellano, Isabelle Carlson, Mark Reznik, Gabriel Siedlecki, James Kane, John Dostalova, Zuzana Miao, Hua Rubin-Bejerano, Ifat |
author_facet | Sansal-Castellano, Isabelle Carlson, Mark Reznik, Gabriel Siedlecki, James Kane, John Dostalova, Zuzana Miao, Hua Rubin-Bejerano, Ifat |
author_sort | Sansal-Castellano, Isabelle |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4652514 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46525142015-11-25 The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody Sansal-Castellano, Isabelle Carlson, Mark Reznik, Gabriel Siedlecki, James Kane, John Dostalova, Zuzana Miao, Hua Rubin-Bejerano, Ifat J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4652514/ http://dx.doi.org/10.1186/2051-1426-3-S2-P414 Text en Copyright © 2015 Sansal-Castellano et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Sansal-Castellano, Isabelle Carlson, Mark Reznik, Gabriel Siedlecki, James Kane, John Dostalova, Zuzana Miao, Hua Rubin-Bejerano, Ifat The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody |
title | The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody |
title_full | The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody |
title_fullStr | The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody |
title_full_unstemmed | The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody |
title_short | The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody |
title_sort | mabxcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-ctla4 antibody |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652514/ http://dx.doi.org/10.1186/2051-1426-3-S2-P414 |
work_keys_str_mv | AT sansalcastellanoisabelle themabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody AT carlsonmark themabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody AT reznikgabriel themabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody AT siedleckijames themabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody AT kanejohn themabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody AT dostalovazuzana themabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody AT miaohua themabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody AT rubinbejeranoifat themabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody AT sansalcastellanoisabelle mabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody AT carlsonmark mabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody AT reznikgabriel mabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody AT siedleckijames mabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody AT kanejohn mabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody AT dostalovazuzana mabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody AT miaohua mabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody AT rubinbejeranoifat mabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody |